Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|September 24, 2008
ASA404: update on drug developmentFarah Rehman, Gordon RustinCurrent Oncology Reports|November 3, 2011
Recurrent ovarian cancer: when and how to treatMarcia Hall, Gordon RustinIn Vivo (Athens, Greece)|December 28, 2018
A Qualitative Analysis of the Impact of Carboplatin AUC 10 on Physical, Work Functioning and Bone Marrow Toxicity Among Seminoma Patients - A Single-centre ExperienceMarina Milic, Marcia Hall, Annette Hawkins, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 30, 2015
Patient Support Groups Identifying Clinical Equipoise in UK Gynaecological Oncology Surgeons as the Basis for Trials in Ultraradical Surgery for Advanced Ovarian CancerRaj Naik, Louise Bayne, Christina Founta, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 19, 2009
Diffusion-weighted MR imaging of female pelvic tumors: a pictorial reviewCharlotte S Whittaker, Andy Coady, Linda Culver, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide productionWilliam J Andrews, Georgia Winnett, Farah Rehman, et al.Cancers|October 27, 2022
A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell TumorsAnand Sharma, Laura Morrison, Marina Milic, et al.Clinical Trials (London, England)|July 27, 2019
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization applicationAndrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)Ajay K Kakkar, Mark N Levine, Zbigniew Kadziola, et al.Archives of Gynecology and Obstetrics|April 5, 2016
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilitiesChristina Fotopoulou, Benjamin P Jones, Konstantinos Savvatis, et al.Pageof 4